Keyword Connections

adverse drug reactions

Journals

12

1 BMC Bioinformatics

2 Applied and environmental microbiology

3 clinical therapeutics

4 Journal of microbiology (Seoul, Korea)

5 European journal of cancer (Oxford, England : 1990)

6 pediatric nephrology (berlin, germany)

7 mmwr morbidity and mortality weekly report

8 epilepsia open

9 emotion (washington, dc)

10 Pulmonary pharmacology & therapeutics

11 indian journal of cancer

12 current allergy and asthma reports

Research Groups

0

No Research Group Connected

Bibliographies

40

1 Adverse drug reaction detection via a multihop self-attention mechanism.

2 Global Versus Indian Perspective of Pioglitazone-induced Adverse Drug Reactions Including Bladder Cancer: A Comparative Retrospective Pharmacovigilance Analysis.

3 Linking entities through an ontology using word embeddings and syntactic re-ranking.

4 The leukotriene receptor antagonist Montelukast can induce adverse skin reactions in asthmatic patients.

5 Correction to: Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis.

6 Yeast viral killer toxin K1 induces specific host cell adaptions via intrinsic selection pressure.

7 Progress Toward Measles Elimination - China, January 2013-June 2019.

8 QuickStats: Percentage* of Adults Aged 18-64 Years Who Had Seen or Talked to a Health Care Professional in the Past 12 Months, by Race/Ethnicity - National Health Interview Survey, 2012-2013 and 2017-2018.

9 "Implications of emotion regulation strategies for empathic concern, social attitudes, and helping behavior": Correction to Lebowitz and Dovidio (2015).

10 Correction to: Basophil Activation Test: Old and New Applications in Allergy.

11 Status of HIV Case-Based Surveillance Implementation - 39 U.S. PEPFAR-Supported Countries, May-July 2019.

12 Erratum: Vol. 68, No. 43.

13 Erratum to: Flavobacterium parvum sp. nov., isolated from soil polluted by sewer water.

14 Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic.

15 extent of poly-pharmacy, occurrence and associated factors of drug-drug interaction and potential adverse drug reactions in gondar teaching referral hospital, north west ethiopia

16 adverse drug reactions in tuberculosis patients due to directly observed treatment strategy therapy: experience at an outpatient clinic of a teaching hospital in the city of imphal, manipur, india

17 reporting of adverse drug reactions due to cardiovascular drugs in india: a national duty

18 Audit of drug-drug interactions and adverse drug reactions due to polypharmacy in older cancer patients: First report from India.

19 adverse affects of drugs on saliva and salivary glands

20 clinical practice guidelines for translating pharmacogenomic knowledge to bedside. focus on anticancer drugs.

21 public awareness and perception toward adverse drug reactions reporting in riyadh, saudi arabia

22 Detecting adverse drug reactions in discharge summaries of electronic medical records using Readpeer.

23 Exposure to anti-malarial drugs and monitoring of adverse drug reactions using toll-free mobile phone calls in private retail sector in Sagamu, Nigeria: implications for pharmacovigilance

24 Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.

25 Methodological framework to identify possible adverse drug reactions using population-based administrative data [v1; ref status: indexed, http://f1000r.es/3ys]

26 Incidence and cost estimate of treating pediatric adverse drug reactions in Lagos, Nigeria

27 Classifying adverse drug reactions from imbalanced twitter data.

28 Data-Driven Extraction of Quantitative Multi-dimensional Associations of Cardiovascular Drugs and Adverse Drug Reactions

29 Averting Alert Fatigue to Prevent Adverse Drug Reactions.

30 Antiretroviral-induced adverse drug reactions in HIV-infected patients in Mali: a resource-limited setting experience.

31 A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology.

32 in vitro release of interferon-gamma from peripheral blood lymphocytes in cutaneous adverse drug reactions

33 awareness among nurses about reporting of adverse drug reactions in sweden

34 seriousness, preventability, and burden impact of reported adverse drug reactions in lombardy emergency departments: a retrospective 2-year characterization

35 the prospective observational study on cutaneous adverse drug reactions to chemotherapy

36 the impact of glutathione s–transferase genotype and phenotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases

37 hospitalization due to adverse drug reactions and drug interactions before and after haart

38 adverse drug reactions reporting culture in pharmacovigilance programme of india

39 prevalence of adverse drug reactions at a private tertiary care hospital in south india

40 pillars and pitfalls of the new pharmacovigilance legislation: consequences for the identification of adverse drug reactions deriving from abuse, misuse, overdose, occupational exposure, and medication errors